« Back to the previous page

Also available in:

Contract research organization in Europe

Company to buy

  • Size: medium-sized business
  • Revenue: 3-30 M EUR
  • Location of the target company: Europe
  • Reason for acquisition: The company wants to acquire a contract research company that has experiences in the 2th and 3th phase of the clinical trials. 
  • Number: #CFIE PHB028 

Overview of the CRO unit wanted 

The buyer wants to acquire Europe based contract research company that has experiences in the 2th and 3th phase of clinical trials and has slightly different capabilities then the presented buyer. 

Profile (strategy) of the CRO buyer   

Large American contract research organization with a huge global footprint which specializes on discovery, preclinical, and clinical drug development services. 

Also offers high quality bioanalytical LC-MS/MS contract services and R&D services with special expertise in Neuropharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, and Clinical Development - Early Phase Clinical Research, Phase II – IV Clinical Research.

Has a sustainable revenue growth and currently employ over 1000 workers in the US, Europe, India and Asia.

Contact us to get details about this pharma company.

Activities and products of the CRO unit

 The buyer would like to acquire a contract research company that operates in Europe and has sufficient expertise and experiences in the 2th and 3th phase of the clinical trials. 

The preferred target should have all the necessary GMP compliance with the scope of modification. The buyer is interested in contract research organization with a yearly turnover between Euro 3-30 million euro. 

Highlights of the CRO buyer

  • A buyer is a large American contract research organization with a huge global footprint which specializes on discovery, preclinical, and clinical drug development services. 
  • Looking to acquire contract research organization that has experiences in the 2th and 3th phase of clinical trials and has slightly different capabilities that the company presented above. 
  • The target should be a pharma packaging solution company with the revenue between (3 – 30 million euro).

Information about this buyer of CRO unit  

Feel free to contact us for more information regarding this contract research organization wanted in Europe or if you know possible interested or suited parties. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.



Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.